The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Basal-Like Breast Cancer: A Critical Review
Abstract
Recent gene expression profiling of breast cancer has identified specific subtypes with clinical, biologic, and therapeutic implications. The basal-like group of tumors is characterized by an expression signature similar to that of the basal/myoepithelial cells of the breast and is reported to have transcriptomic characteristics similar to those of tumors arising in BRCA1 germline mutation carriers. They are associated with aggressive behavior and poor prognosis, and typically do not express hormone receptors or HER-2 (“triple-negative” phenotype). Therefore, patients with basal-like cancers are unlikely to benefit from currently available targeted systemic therapy. Although basal-like tumors are characterized by distinctive morphologic, genetic, immunophenotypic, and clinical features, neither an accepted consensus on routine clinical identification and definition of this aggressive subtype of breast cancer nor a way of systematically classifying this complex group of tumors has been described. Different definitions are, therefore, likely to produce variable and contradictory results that may hamper consistent identification and development of treatment strategies for these tumors. In this review, we discuss definition, heterogeneity, morphologic spectrum, relation to BRCA1, and clinical significance of this important class of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Moll, R., Franke, W. W., Schiller, D. L., Geiger, B., & Krepler, R. (1982) · Cell · doi:10.1016/0092-8674(82)90400-7 · Cited by 5,247
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., Ollila, D. W., Sartor, C. I., Graham, M. L., & Perou, C. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1109 · Cited by 2,087
Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891
Pathological prognostic factors in breast cancer
Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
The molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Prognostic markers in triple‐negative breast cancer
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F., & Ellis, I. O. (2007) · Cancer · doi:10.1002/cncr.22381 · Cited by 1,283
Self-citationBRCA1 Mutations in Primary Breast and Ovarian Carcinomas
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., et al. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,205
Haffty, B. G., Yang, Q., Reiss, M., Kearney, T., Higgins, S. A., Weidhaas, J., Harris, L., Hait, W., & Toppmeyer, D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5664 · Cited by 1,084
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063
Chang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
Foulkes, W. D. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg050 · Cited by 970
The Zinc Finger-containing Transcription Factors GATA-4, -5, and -6
Molkentin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000029200 · Cited by 880
X chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869
Lakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
van der Groep, P., Bouter, A., van der Zanden, R., Menko, F. H., Buerger, H., Verheijen, R. H. M., van der Wall, E., & van Diest, P. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh114 · Cited by 798
Epidermal Growth Factor Receptor Targeting in Cancer
MENDELSOHN, J., & BASELGA, J. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.003 · Cited by 693
Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5
Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K., & Quaranta, V. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.3.615 · Cited by 655
Lakhani, S. R., Reis-Filho, J. S., Fulford, L., Penault-Llorca, F., van der Vijver, M., Parry, S., Bishop, T., Benitez, J., Rivas, C., Bignon, Y.-J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2424 · Cited by 611
Self-citationAbd El‐Rehim, D. M., Ball, G., Pinder, S. E., Rakha, E., Paish, C., Robertson, J. F. R., Macmillan, D., Blamey, R. W., & Ellis, I. O. (2005) · International Journal of Cancer · doi:10.1002/ijc.21004 · Cited by 606
Self-citationExpression of luminal and basal cytokeratins in human breast carcinoma
Abd El‐Rehim, D. M., Pinder, S. E., Paish, C. E., Bell, J., Blamey, R., Robertson, J. F., Nicholson, R. I., & Ellis, I. O. (2004) · The Journal of Pathology · doi:10.1002/path.1559 · Cited by 594
Self-citationBRCA1 dysfunction in sporadic basal-like breast cancer
Turner, N. C., Reis-Filho, J. S., Russell, A. M., Springall, R. J., Ryder, K., Steele, D., Savage, K., Gillett, C. E., Schmitt, F. C., Ashworth, A., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210014 · Cited by 573
Self-citationvan de Rijn, M., Perou, C. M., Tibshirani, R., Haas, P., Kallioniemi, O., Kononen, J., Torhorst, J., Sauter, G., Zuber, M., Köchli, O. R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64476-8 · Cited by 560
Bergamaschi, A., Kim, Y. H., Wang, P., Sørlie, T., Hernandez‐Boussard, T., Lonning, P. E., Tibshirani, R., Børresen‐Dale, A., & Pollack, J. R. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20366 · Cited by 506
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
Fan, S., Wang, J.-A., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1354 · Cited by 491
Basal-like breast cancer and the BRCA1 phenotype
Turner, N. C., & Reis-Filho, J. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209876 · Cited by 478
Self-citationDifferent Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
Zhao, H., Langerød, A., Ji, Y., Nowels, K. W., Nesland, J. M., Tibshirani, R., Bukholm, I. K., Kåresen, R., Botstein, D., Børresen-Dale, A.-L., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0786 · Cited by 445
The Role of BRCA1 in the Cellular Response to Chemotherapy
Kennedy, R. D., Quinn, J. E., Mullan, P. B., Johnston, P. G., & Harkin, D. P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh312 · Cited by 430
Targeting the epidermal growth factor receptor for cancer therapy.
Mendelsohn, J. M. (2002) · PubMed · Cited by 414
Finn, R. S., Dering, J., Ginther, C., Wilson, C. A., Glaspy, P., Tchekmedyian, N., & Slamon, D. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9463-x · Cited by 409
Sørlie, T., Wang, Y., Xiao, C., Johnsen, H., Naume, B., Samaha, R. R., & Børresen-Dale, A.-L. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-127 · Cited by 387
Antibody markers of basal cells in complex epithelia
Purkis, P. E., Steel, J. B., Mackenzie, I. C., Nathrath, W. B. J., Leigh, I. M., & Lane, E. B. (1990) · Journal of Cell Science · doi:10.1242/jcs.97.1.39 · Cited by 379
Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue
Stingl, J., Eaves, C. J., Zandieh, I., & Emerman, J. T. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010615124301 · Cited by 367
Foulkes, W. D., Brunet, J.-S., Stefansson, I. M., Straume, O., Chappuis, P. O., Bégin, L. R., Hamel, N., Goffin, J. R., Wong, N., Trudel, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2970 · Cited by 363
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
Fulford, L. G., Easton, D. F., Reis‐Filho, J. S., Sofronis, A., Gillett, C. E., Lakhani, S. R., & Hanby, A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02453.x · Cited by 352
Self-citationHuang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., & Clark, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3633 · Cited by 344
Metaplastic breast carcinomas are basal‐like tumours
Reis‐Filho, J. S., Milanezi, F., Steele, D., Savage, K., Simpson, P. T., Nesland, J. M., Pereira, E. M., Lakhani, S. R., & Schmitt, F. C. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02467.x · Cited by 341
Self-citationLazard, D., Sastre, X., Frid, M. G., Glukhova, M. A., Thiery, J. P., & Koteliansky, V. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.999 · Cited by 334
Rhodes, A., Jasani, B., Barnes, D. M., Bobrow, L. G., & Miller, K. D. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.2.125 · Cited by 325
Rodríguez-Pinilla, S. M., Sarrió, D., Honrado, E., Hardisson, D., Calero, F., Benitez, J., & Palacios, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2281 · Cited by 324
Novel patterns of genome rearrangement and their association with survival in breast cancer
Hicks, J., Krasnitz, A., Lakshmi, B., Navin, N. E., Riggs, M., Leibu, E., Esposito, D., Alexander, J., Troge, J., Grubor, V., et al. (2006) · Genome Research · doi:10.1101/gr.5460106 · Cited by 319
Rakha, E., Putti, T., Abd El‐Rehim, D., Paish, C., Green, A., Powe, D., Lee, A., Robertson, J., & Ellis, I. (2006) · The Journal of Pathology · doi:10.1002/path.1916 · Cited by 311
Self-citationFulford, L. G., Reis-Filho, J. S., Ryder, K., Jones, C., Gillett, C. E., Hanby, A., Easton, D., & Lakhani, S. R. (2007) · Breast Cancer Research · doi:10.1186/bcr1636 · Cited by 306
Self-citationBRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome
Ganesan, S., Silver, D. P., Greenberg, R. A., Avni, D., Drapkin, R., Miron, A., Mok, S. C., Randrianarison, V., Brodie, S., Salstrom, J., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01052-8 · Cited by 302
TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Langerød, A., Zhao, H., Borgan, Ø., Nesland, J. M., Bukholm, I. R., Ikdahl, T., Kåresen, R., Børresen-Dale, A.-L., & Jeffrey, S. S. (2007) · Breast Cancer Research · doi:10.1186/bcr1675 · Cited by 291
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
Banerjee, S., Reis-Filho, J. S., Ashley, S., Steele, D., Ashworth, A., Lakhani, S. R., & Smith, I. E. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.033043 · Cited by 290
Self-citationGusterson, B. A., Ross, D. T., Heath, V. J., & Stein, T. (2005) · Breast Cancer Research · doi:10.1186/bcr1041 · Cited by 282
Towards a novel classification of human malignancies based on gene expression patterns
Alizadeh, A. A., Ross, D. T., Perou, C. M., & van de Rijn, M. (2001) · The Journal of Pathology · doi:10.1002/path.889 · Cited by 280
B-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
Moyano, J. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25888 · Cited by 272
Nagle, R. B., Böcker, W., Davis, J. R., Heid, H. W., Kaufmann, M., Lucas, D. O., & Jarasch, E. D. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.7.2423579 · Cited by 270
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
Reis‐Filho, J., Pinheiro, C., Lambros, M., Milanezi, F., Carvalho, S., Savage, K., Simpson, P., Jones, C., Swift, S., Mackay, A., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2004 · Cited by 266
Self-citationHicks, D. G., Short, S. M., Prescott, N. L., Tarr, S. M., Coleman, K. A., Yoder, B. J., Crowe, J. P., Choueiri, T. K., Dawson, A. E., Budd, G. T., et al. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213306.05811.b9 · Cited by 262
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Calza, S., Hall, P., Auer, G., Bjöhle, J., Klaar, S., Kronenwett, U., Liu, E. T., Miller, L., Ploner, A., Smeds, J., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1517 · Cited by 262
Breast cancer: metastatic patterns and their prognosis.
Patanaphan, V., Om, S., & Risco, R. (1988) · PubMed · Cited by 260
Wessels, L. F. A., van Welsem, T., Hart, A. A. M., Veer, L. J. V., Reinders, M. J. T., & Nederlof, P. M. (2002) · PubMed · Cited by 252
Rice, J. C., Massey-Brown, K. S., & Futscher, B. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202086 · Cited by 243
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Rodriguez-Pinilla, S. M., Sarrio, D., Moreno-Bueno, G., Rodriguez-Gil, Y., Martinez, M. A., Hernandez, L., Hardisson, D., Reis-Filho, J. S., & Palacios, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800760 · Cited by 242
Self-citationTargeting the TGFβ signaling network in human neoplasia
Dumont, N., & Arteaga, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00135-1 · Cited by 242
Korsching, E., Packeisen, J., Agelopoulos, K., Eisenacher, M., Voss, R., Isola, J., van Diest, P. J., Brandt, B., Boecker, W., & Buerger, H. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000038508.86221.b3 · Cited by 238
G�rtner, F., Schmitt, F. C., Preto, A., Reis-Filho, J. S., Simpson, P. T., & Martins, A. (2003) · Virchows Archiv · doi:10.1007/s00428-003-0859-2 · Cited by 235
Self-citationMatos, I., Dufloth, R., Alvarenga, M., Zeferino, L. C., & Schmitt, F. (2005) · Virchows Archiv · doi:10.1007/s00428-005-0010-7 · Cited by 227
Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes
Loo, L. W. M., Grove, D. I., Williams, E. M., Neal, C. L., Cousens, L. A., Schubert, E. L., Holcomb, I. N., Massa, H. F., Glogovac, J., Li, C. I., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1992 · Cited by 222
Breast Cancer: Metastatic Patterns and Their Prognosis
PATANAPHAN, V., SALAZAR, O. M., & RISCO, R. (1988) · Southern Medical Journal · doi:10.1097/00007611-198809000-00011 · Cited by 221
Bryan, B. B., Schnitt, S. J., & Collins, L. C. (2006) · Modern Pathology · doi:10.1038/modpathol.3800570 · Cited by 217
Collett, K., Stefansson, I. M., Eide, J., Braaten, A., Wang, H., Eide, G. E., Thoresen, S. Ø., Foulkes, W. D., & Akslen, L. A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0394 · Cited by 215
Identification of a basal-like subtype of breast ductal carcinoma in situ
Livasy, C. A., Perou, C. M., Karaca, G., Cowan, D. W., Maia, D., Jackson, S., Tse, C.-K., Nyante, S., & Millikan, R. C. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.08.017 · Cited by 215
Page, M. J., Amess, B., Townsend, R. R., Parekh, R., Herath, A., Brusten, L., Zvelebil, M. J., Stein, R. C., Waterfield, M. D., Davies, S. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12589 · Cited by 209
Savage, K., Lambros, M. B. K., Robertson, D., Jones, R. L., Jones, C., Mackay, A., James, M., Hornick, J. L., Pereira, E. M., Milanezi, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1371 · Cited by 206
Self-citationPerreard, L., Fan, C., Quackenbush, J. F., Mullins, M., Gauthier, N. P., Nelson, E., Mone, M., Hansen, H., Buys, S. S., Rasmussen, K., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1399 · Cited by 205
Typical medullary breast carcinomas have a basal/myoepithelial phenotype
Jacquemier, J., Padovani, L., Rabayrol, L., Lakhani, S. R., Penault‐Llorca, F., Denoux, Y., Fiche, M., Figueiro, P., Maisongrosse, V., Ledoussal, V., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1845 · Cited by 202
Epithelial (E‐) and placentae (P‐) cadherin cell adhesion molecule expression in breast carcinoma
Rasbridge, S. A., Gillett, C. E., Sampson, S. A., Walsh, F. S., & Millis, R. R. (1993) · The Journal of Pathology · doi:10.1002/path.1711690211 · Cited by 201
Chemoprevention of Breast Cancer: A Model for Change
Jordan, V. C., & Morrow, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.1 · Cited by 197
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
Rakha, E. A., El-Rehim, D. A., Paish, C., Green, A. R., Lee, A. H. S., Robertson, J. F., Blamey, R. W., Macmillan, D., & Ellis, I. O. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.015 · Cited by 193
Self-citationCytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
Laakso, M., Loman, N., Borg, Å., & Isola, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800456 · Cited by 190
Wang, Z. C., Lin, M., Wei, L.-J., Li, C., Miron, A., Lodeiro, G., Harris, L., Ramaswamy, S., Tanenbaum, D. M., Meyerson, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2570 · Cited by 190
Vincent-Salomon, A., Gruel, N., Lucchesi, C., MacGrogan, G., Dendale, R., Sigal-Zafrani, B., Longy, M., Raynal, V., Pierron, G., de Mascarel, I., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1666 · Cited by 188
Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
Wetzels, R. H. W., Kuijpers, H. J. H., Lane, E. B., Leigh, I. M., Troyanovsky, S. M., Holland, R., van Haelst, U. J. G. M., & Ramaekers, F. C. S. (1991) · PubMed Central · Cited by 183
BRCA1 functions as a breast stem cell regulator
Foulkes, W. D. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013805 · Cited by 183
Palacios, J., Honrado, E., Osório, A., Cazorla, A., Sarrió, D., Barroso, A., Rodríguez, S., Cigudosa, J. C., Dı́ez, O., Alonso, C., et al. (2003) · PubMed · Cited by 175
Gene expression profiling of primary breast carcinomas using arrays of candidate genes
Bertucci, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.2981 · Cited by 175
Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations
Stoppa-Lyonnet, D., Ansquer, Y., Dreyfus, H., Gautier, C., Gauthier-Villars, M., Bourstyn, E., Clough, K. B., Magdelénat, H., Pouillart, P., Vincent-Salomon, A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4053 · Cited by 174
Malzahn, K., Mitze, M., Thoenes, M., & Moll, R. (1998) · Virchows Archiv · doi:10.1007/s004280050226 · Cited by 174
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Paish, E. C., Lee, A. H. S., & Ellis, I. O. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02638.x · Cited by 169
Self-citationBRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles
Matros, E., Wang, Z. C., Lodeiro, G., Miron, A., Iglehart, J. D., & Richardson, A. L. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-7603-8 · Cited by 167
Identification and validation of an ERBB2 gene expression signature in breast cancers
Bertucci, F., Borie, N., Ginestier, C., Groulet, A., Charafe‐Jauffret, E., Adélaïde, J., Geneix, J., Bachelart, L., Finetti, P., Koki, A. T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207361 · Cited by 164
Targeting the DNA repair defect of BRCA tumours
TURNER, N., TUTT, A., & ASHWORTH, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.006 · Cited by 164
Jönsson, G., Naylor, T. L., Vallon-Christersson, J., Staaf, J., Huang, J., Ward, M. R., Greshock, J. D., Luts, L., Olsson, H., Rahman, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0570 · Cited by 163
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
Gaedcke, J., Traub, F., Milde, S., Wilkens, L., Stan, A. C., Ostertag, H., Christgen, M., von Wasielewski, R., & Kreipe, H. H. (2007) · Modern Pathology · doi:10.1038/modpathol.3800830 · Cited by 161
BRCA1, a Potential Predictive Biomarker in the Treatment of Breast Cancer
James, C. R., Quinn, J. E., Mullan, P. B., Johnston, P. G., & Harkin, D. P. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-142 · Cited by 160
Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer
Arnes, J. B., Brunet, J.-S., Stefansson, I., Bégin, L. R., Wong, N., Chappuis, P. O., Akslen, L. A., & Foulkes, W. D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2064 · Cited by 158
Garcia, S., Dalès, J.-P., Charafe‐Jauffret, E., Carpentier-Meunier, S., Andrac, L., Jacquemier, J. D., Andonian, C., Lavaut, M., Allasia, C., Bonnier, P., et al. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.015 · Cited by 156
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer: Table 1
Chappuis, P. O., Goffin, J., Wong, N., Perret, C., Ghadirian, P., Tonin, P. N., & Foulkes, W. D. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.608 · Cited by 156
Deconstructing the molecular portrait of basal-like breast cancer
Yehiely, F., Moyano, J. V., Evans, J. R., Nielsen, T. O., & Cryns, V. L. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.004 · Cited by 144
Multiple Functions of the Integrin α6β4 in Epidermal Homeostasis and Tumorigenesis
Wilhelmsen, K., Litjens, S. H. M., & Sonnenberg, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2877-2886.2006 · Cited by 144
A mouse model of basal‐like breast carcinoma with metaplastic elements
McCarthy, A., Savage, K., Gabriel, A., Naceur‐Lombardelli, C., Reis‐Filho, J., & Ashworth, A. (2007) · The Journal of Pathology · doi:10.1002/path.2124 · Cited by 144
Self-citationBoecker, W., & Buerger, H. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.36.s.1.7.x · Cited by 143
Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells
Furuta, S., Jiang, X., Gu, B., Cheng, E., Chen, P., & Lee, W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503793102 · Cited by 142
Linkage between EGFR family receptors and nuclear factor kappaB (NF‐κB) signaling in breast cancer
Biswas, D. K., & Iglehart, J. D. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20785 · Cited by 140
Letessier, A., Sircoulomb, F., Ginestier, C., Cervera, N., Monville, F., Gelsi‐Boyer, V., Esterni, B., Geneix, J., Finetti, P., Zemmour, C., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-245 · Cited by 139
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile
Dabbs, D. J., Chivukula, M., Carter, G. J., & Bhargava, R. (2006) · Modern Pathology · doi:10.1038/modpathol.3800678 · Cited by 139
Jones, C., Ford, E., Gillett, C., Ryder, K., Merrett, S., Reis-Filho, J. S., Fulford, L. G., Hanby, A. M., & Lakhani, S. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0731 · Cited by 139
Self-citationRodríguez-Pinilla, S. M., Honrado, E., Hardisson, D., Benitez, J. J., & Palacios, J. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9184-1 · Cited by 135
Jumppanen, M., Gruvberger-Saal, S. K., Kauraniemi, P., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1649 · Cited by 132
Li, H., Cherukuri, P., Li, N., Cowling, V. H., Spinella, M. J., Cole, M. D., Godwin, A. K., Wells, W. A., & DiRenzo, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-05-4571 · Cited by 127
Laakso, M., Tanner, M., Nilsson, J. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0353 · Cited by 116
Reis-Filho, J. S., Steele, D., Palma, S. D., Jones, R. L., Savage, K., James, M., Milanezi, F., Schmitt, F. C., & Ashworth, A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800542 · Cited by 105
Self-citationRodríguez-Pinilla, S. M., Sarrió, D., Honrado, E., Moreno‐Bueno, G., Hardisson, D., Calero, F., Benitez, J. J., & Palacios, J. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.042143 · Cited by 104
Prognostic Relevance of Basal Cytokeratin Expression in Operable Breast Cancer
Potemski, P., Kusińska, R., Watała, C. W., Płuciennik, E., Bednarek, A. K., & Kordek, R. (2005) · Oncology · doi:10.1159/000090986 · Cited by 102
KIT (CD117)-Positive Breast Cancers Are Infrequent and Lack KIT Gene Mutations
Simon, R., Panussis, S., Maurer, R. E., Spichtin, H., Glatz, K., Tapia, C., Mirlacher, M., Rufle, A., Torhorst, J. K. H., & Sauter, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0597-3 · Cited by 102
P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast
Paredes, J., Milanezi, F., Viegas, L. C., et al. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100487 · Cited by 71
Soto, J. A. D., & Deng, C. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.117 · Cited by 71
Zhang, R. R., Man, Y.-G., VANG, R. S., Saenger, J. S., Barner, R., Wheeler, D. T., Liang, C. Y., Vinh, T. N., & Bratthauer, G. L. (2003) · Breast Cancer Research · doi:10.1186/bcr635 · Cited by 70
Sporadic Invasive Breast Carcinomas With Medullary Features Display a Basal-like Phenotype
Rodríguez-Pinilla, S. M., Rodríguez‐Gil, Y., Moreno‐Bueno, G., Sarrió, D., Martín-Guijarro, M. D. C., Hernández, L., & Palacios, J. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213427.84245.92 · Cited by 64
Nakano, S., Iyama, K. I., Ogawa, M., et al. (1999) · PubMed · Cited by 55
MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCER
Dairkee, S. H., Mayall, B., Smith, H. S., & Hackett, A. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92129-5 · Cited by 51
Cited by
Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,157
Self-citationTriple negative tumours: a critical review
Reis‐Filho, J. S., & Tutt, A. N. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02889.x · Cited by 884
Self-citationIntrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318376111 · Cited by 877
Molyneux, G., Geyer, F. C., Magnay, F.-A., McCarthy, A., Kendrick, H., Natrajan, R., MacKay, A., Grigoriadis, A., Tutt, A., Ashworth, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.07.010 · Cited by 794
Self-citationAn overview of triple-negative breast cancer
Kumar, P., & Aggarwal, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3859-y · Cited by 771
Metadata
- Authors
- Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-05-20
- Volume
- 26
- Issue
- 15
- Pages
- 2568-2581
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2120512382
- Cited by
- 1,164
- References
- 130
- FWCI
- 28.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.